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Visualizing the Vascular Glue
“Shearing” the Barriers to Atherosclerotic Plaque Imaging*
Peter Libby, MD, Kevin Croce, MD, PHD
Boston, MassachusettsAdvances in cardiovascular imaging have accompa-
nied the growth of this specialty for more than a
century, and imaging modalities that primarily in-
terrogate anatomical or structural features of the
heart and vasculature continue to increase in reso-
lution and sophistication. As understanding grows
about the biological underpinnings of cardiovascu-
lar disease, new opportunities emerge for harnessing
discoveries about molecular pathobiology to de-
velop novel cardiovascular imaging approaches.
See page 947
Forays into the molecular imaging of atherosclerosis
to date have targeted processes implicated in the
genesis of atherosclerotic plaques. Leukocyte adhe-
sion molecules, oxidatively modified lipoproteins,
phagocytic activity of inflammatory cells, and active
proteases exemplify targets for functional imaging
of atherosclerosis that extend beyond anatomy and
hold the promise of defining disease activity and
elucidating atherothrombotic risk (1). Many molec-
ular targets of atherosclerosis imaging increase di-
rectly with disease activity and contribute to lesion
initiation and progression. Ultimately, the most
dramatic clinical complications of atherosclerosis
involve thrombosis. Visualizing molecular aspects
of thrombosis thus may provide a window into
aspects of plaque biology that are more proximate to
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in the course of the disease.
In this regard, visualization of thrombi through
the incorporation of radioactively labeled fibrinogen
furnishes an early example of molecular imaging of
thrombosis (2). More recently, visualization of the
transglutaminase activity of factor XIII in the co-
agulation cascade (3), and visualization of tissue
factor bearing microparticle (4) and platelet (5)
incorporation into developing thrombi, have pro-
vided additional windows for clot detection through
cellular and molecular imaging. Fibrin plays a fun-
damental role in both venous and arterial thrombus
formation, yet platelet involvement characterizes ar-
terial clots (the “white” thrombus) in particular. De-
spite advances in many areas, approaches to the
molecular imaging of atherosclerosis have not ad-
dressed superficial erosion of atherosclerotic plaques, a
mechanism that causes many fatal coronary thrombi,
especially in women and the elderly (6).
In this issue of iJACC, McCarty et al. (7) have
exploited the molecular complexes that mediate
platelet adhesion under arterial shear forces to
enable molecular imaging of atherosclerosis and
superficial plaque erosion with a clever and innova-
tive strategy. This approach uses contrast-enhanced
ultrasound targeting with glycoprotein Ib 
(GPIb) to detect activated von Willebrand factor
(vWF) in mice as a means to probe characteristics
found in human plaques that have caused fatal
thrombosis.
In the normal artery, vWF resides in endothelial
intracellular secretory compartments known as
Weibel-Palade bodies and in intracellular
-secretory granules in platelets (Fig. 1). Under
normal circumstances, resting endothelial cells de-
posit vWF in a subendothelial location on the
basement membrane underlying the intimal mono-
layer of endothelial cells. When activated, endothe-
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957ial cells can expel their granular Weibel-Palade
ontents, releasing pre-formed vWF. When an
ndothelial cell sloughs from the intimal surface—a
rocess invoked in superficial erosion of atheroscle-
otic plaques—the prothrombotic vWF-laden sub-
ndothelial carpet becomes exposed, and platelet
eposition occurs. After its release from endothelial
ells and platelets, vWF self-assembles into multi-
eric linear complexes, a process that requires the
resence of high shear forces that prevail in flowing
rterial blood. Arterial shear also induces confor-
ational protein changes in vWF multimers, ex-
osing high-affinity binding sites for the platelet
urface receptor GPIb. GPIb-vWF-mediated
latelet bridging results in platelet aggregation.
hese tethers between the activated vWF multim-
rs resist disaggregation by blood flow even at high
hear rates (Fig. 1). Prothrombotic factors such as
hrombin and adenosine diphosphate (ADP) acti-
ate vWF bound platelets and initiate secretion of
-granular vWF, which further amplifies thrombus
ormation in a positive feedback manner. Activated
WF released by degranulating endothelial cells and
latelets joins circulating vWF to form large mul-
imers that potently promote further platelet bridg-
Figure 1. Endothelial Cells Store Pre-Formed vWF in Intracellula
Intracellular -Secretory Granules
Activated endothelial cells release von Willebrand factor (vWF), whi
surface receptor glycoprotein Ib. Once activated, platelets themse
vWF in the subendothelial basement membrane, detection of activa
thelial desquamation. Endothelial desquamation is a characteristic f
to 30% of acute fatal myocardial infarctions. This novel strategy of
visualization of several features of atherosclerotic plaques prone to
sive arterial thrombosis. Figure illustration by Craig Skaggs.ng and aggregation. bThe study by McCarty et al. (7) demonstrated
hat GPIb-conjugated contrast-enhanced ultra-
ound bubbles attached to vWF multimers under
onditions of arterial blood flow in vitro, and that
PIb-targeted microbubbles bound injured artery
egments and atheromata with greater avidity, as
ompared with nonatheromatous arterial segments
r with normal arteries in vivo. These data indicate
hat molecular imaging of activated vWF may
dentify plaques with a particular propensity to
nitiate arterial thrombosis, and that vWF-targeted
maging has the potential to detect preferentially
uperficial erosion of the endothelium—an elusive
spect of plaque biology that has evaded detection
y other modalities. Thus activated vWF imaging
ight not only enable novel characterization of the
olecular events that occur during atherothrombo-
is, but might also enable the identification of
enuded intimal segments that initiate platelet ad-
esion and arterial thrombosis.
Curiously, although we use genetically altered
ice to study atherogenesis extensively, the athero-
clerotic arteries in this species seldom develop
cclusive thrombi, an important distinction from
he process in humans. Although the contrast-to-
eibel-Palade Storage Granules and Platelets Store vWF in
an form multimers that bridge platelets through binding of the
can release pre-formed vWF. Because endothelial cells deposit
vWF provides an avenue to the visualization of regions of endo-
re of superﬁcial atherosclerotic plaque erosion, which causes 20%
rast-enhanced ultrasound targeting activated vWF could permit
se late-stage atherothrombotic complications that result in occlu-r W
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958cCarty et al. (7) may seem modest, one might
xpect higher signals in human lesions, where there
s larger plaque mass and obstructive atherosclerotic
laques generate post-stenotic pathological shear
ates of 10,000s1 that markedly enhance GPIb-
WF interaction (8–10). In addition, many his-
opathological studies of human atherosclerosis
uggest that thrombosis in situ and superficial
rosion comprise more prominent features of ath-
rosclerotic disease in humans than in rodents. The
igher prevalence of superficial erosion might pos-
tively impact the signal-to-background ratios, sen-
itivity, and clinical utility of vWF imaging indent upon microparticle P-selectin independent platelef superficial erosion and platelet activation, this
ovel molecular imaging strategy has great appeal as
gauge of atherosclerotic plaque prothrombotic
ctivity related to late-stage complications that
recipitate many fatal acute coronary syndromes.
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